Nolan DA - Search Results

1

Randomized, controlled, 48-week study of switching stavudine and/or protease inhibitors to combivir/abacavir to prevent or reverse lipoatrophy in HIV-infected patients.

John M, McKinnon EJ, James IR, Nolan DA, Herrmann SE, Moore CB, White AJ, Mallal SA. John M, et al. Among authors: nolan da. J Acquir Immune Defic Syndr. 2003 May 1;33(1):29-33. doi: 10.1097/00126334-200305010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12792352 Clinical Trial.

2

Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy.

Nolan D, Hammond E, Martin A, Taylor L, Herrmann S, McKinnon E, Metcalf C, Latham B, Mallal S. Nolan D, et al. AIDS. 2003 Jun 13;17(9):1329-38. doi: 10.1097/00002030-200306130-00007. AIDS. 2003. PMID: 12799554

3

Thymidine analogue-sparing highly active antiretroviral therapy (HAART).

Nolan D, Mallal S. Nolan D, et al. J HIV Ther. 2003 Feb;8(1):2-6. J HIV Ther. 2003. PMID: 12840707 Review.

4

Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level.

Nolan D, Hammond E, James I, McKinnon E, Mallal S. Nolan D, et al. Antivir Ther. 2003 Dec;8(6):617-26. Antivir Ther. 2003. PMID: 14760896

5

The role of nucleoside reverse transcriptase inhibitors in the fat redistribution syndrome.

Nolan D, Mallal S. Nolan D, et al. J HIV Ther. 2004 May;9(2):34-40. J HIV Ther. 2004. PMID: 15238874 Review.

6

Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms.

Nolan D, Mallal S. Nolan D, et al. Antivir Ther. 2004 Dec;9(6):849-63. Antivir Ther. 2004. PMID: 15651744 Review.

7

Antiretroviral-therapy-associated lipoatrophy: current status and future directions.

Nolan D, Mallal S. Nolan D, et al. Sex Health. 2005;2(3):153-63. doi: 10.1071/sh04058. Sex Health. 2005. PMID: 16335543 Review.

8

Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals.

Cherry CL, Nolan D, James IR, McKinnon EJ, Mallal SA, Gahan ME, Lal L, McArthur JC, Wesselingh SL. Cherry CL, et al. J Acquir Immune Defic Syndr. 2006 Aug 1;42(4):435-40. doi: 10.1097/01.qai.0000224974.67962.ce. J Acquir Immune Defic Syndr. 2006. PMID: 16810110

9

Cytokine profiling in abacavir hypersensitivity patients.

Almeida CA, Martin AM, Nolan D, Lucas A, Cameron PU, James I, Phillips E, Mallal S. Almeida CA, et al. Antivir Ther. 2008;13(2):281-8. Antivir Ther. 2008. PMID: 18505179

10

Human immunodeficiency virus treatment-induced adipose tissue pathology and lipoatrophy: prevalence and metabolic consequences.

Hammond E, McKinnon E, Nolan D. Hammond E, et al. Clin Infect Dis. 2010 Sep 1;51(5):591-9. doi: 10.1086/655765. Clin Infect Dis. 2010. PMID: 20645860 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters